The Paris Bourse should stand still at the opening Wednesday, the lack of major information prompting investors to extend the break from the day before.
At around 8:15 am, the ‘future’ contract on the CAC 40 index – expiring at the end of the month – lost around 13 points to 5,470 points, announcing a slight decline in the start of the session.
The Parisian market had ended on a modest increase yesterday, taking up 0.2% to 5482 points, very close to its highs of the day (5487 points) and a few cables from the threshold of 5500 points.
If the buyers seem to be in control, volumes remained relatively mediocre with 3.75 billion euros traded and the session was not very volatile.
A certain calm continues to reign on the markets this morning in the absence of major economic events and the lack of information concerning the development of new vaccines, the main concern of investors for ten days.
In Asia, variations remained limited on Wednesday, especially in China, where the CSI 300 index of large caps retroceded less than 0.1% at the end of the session.
On the Tokyo Stock Exchange, the Nikkei index showed losses of around 1.1%, victim of logical profit-taking after soaring 13% in ten sessions.
‘Yesterday, the chief financial officer of AstraZeneca said that the results of phase III would be available within a few days, or even a few weeks’, it is stressed however at Danske Bank.
“The CEO of Pfizer announced for his part that the group was preparing to file its data with the US Food & Drug Administration”, adds the Danish bank.
Good news is sure to fuel the uptrend in the markets and allow the stock market to end on hats.
On the other hand, today’s session promises to be relatively calm in terms of statistics, with a macroeconomic agenda that promises to be rather meager despite the publication, in the United States, of the latest real estate figures and the publication, in Europe, of inflation in the euro zone.
Copyright (c) 2020 CercleFinance.com. All rights reserved.